Prognostic factors in postoperative radiotherapy for prostate cancer – tertiary center experience Cover

.blurhash-client-img { display: none !important; }

Prognostic factors in postoperative radiotherapy for prostate cancer – tertiary center experience

Radiology and Oncology

Volume 55 (2021): Issue 2 (June 2021)

By: Marcin Miszczyk, Wojciech Majewski, Konrad Stawiski, Konrad Rasławski, Paweł Rajwa, Iwona Jabłońska, Łukasz Magrowski, Oliwia Masri, Andrzej Paradysz and Leszek Miszczyk

Open Access

|Mar 2021

Authors

Marcin Miszczyk

marcinmmiszczyk@gmail.com

Gliwice, Poland

Wojciech Majewski

Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland

Konrad Stawiski

Department of Biostatistics and Translational Medicine, Medical University of Łodź, Łódź, Poland

Konrad Rasławski

Gliwice, Poland

Paweł Rajwa

Department of Urology, Medical University of Silesia, Zabrze, Poland

Iwona Jabłońska

Gliwice, Poland

Łukasz Magrowski

Gliwice, Poland

Oliwia Masri

Gliwice, Poland

Andrzej Paradysz

Department of Urology, Medical University of Silesia, Zabrze, Poland

Leszek Miszczyk

Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland

DOI: https://doi.org/10.2478/raon-2021-0017 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 203 - 211

Submitted on: Nov 20, 2020

|

Accepted on: Feb 6, 2021

|

Published on: Mar 25, 2021

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

prostate cancer,

prognostic factors,

postoperative radiotherapy,

disease-free survival

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2021 Marcin Miszczyk, Wojciech Majewski, Konrad Stawiski, Konrad Rasławski, Paweł Rajwa, Iwona Jabłońska, Łukasz Magrowski, Oliwia Masri, Andrzej Paradysz, Leszek Miszczyk, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 55 (2021): Issue 2 (June 2021)Next article